Učitavanje...
Pharmacologic Management of Duchenne Muscular Dystrophy: Target Identification and Preclinical Trials
Duchenne muscular dystrophy (DMD) is an X-linked human disorder in which absence of the protein dystrophin causes degeneration of skeletal and cardiac muscle. For the sake of treatment development, over and above definitive genetic and cell-based therapies, there is considerable interest in drugs th...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4158345/ https://ncbi.nlm.nih.gov/pubmed/24936034 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ilar/ilu011 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|